PURPOSE: @entity1 decisions to seek treatment for @entity2182 are influenced by the impact of the condition on health related quality of life and the presence of prescription insurance coverage. This study uses conjoint analysis to examine the relative importance of health related quality of life dimensions of the @entity2182 questionnaire and the presence of prescription insurance coverage on @entity1 preference for treatment. MATERIALS AND METHODS: @entity1 preferences were elicited using a study questionnaire that included 9 hypothetical profiles containing an orthogonal array of attributes relating to coping with symptoms, symptom concern, @entity25 , problems with social interactions and prescription insurance coverage. This questionnaire was administered to 150 @entity1 with self-reported symptoms of @entity2182 . @entity1 responded to each profile with the likelihood that they would prefer drug therapy to control @entity2182 symptoms versus doing nothing. RESULTS: A total of 133 usable responses were obtained from @entity1 . Analysis was conducted with a linear random effects model. Of the 5 included attributes prescription insurance coverage was the most important attribute followed by @entity25 , symptom concern, social interaction problems and coping. Responses obtained from attribute ratings using visual analog scaling and a holdout profile demonstrated study validity. CONCLUSIONS: Prescription insurance coverage and @entity25 are important considerations underlying @entity1 preferences for the treatment of @entity2182 .

The relative importance of health related quality of life and prescription insurance coverage in the decision to pharmacologically manage symptoms of XXXX .

@entity1 :: ('9606', 'Species') :: ['participants', 'Patients', 'patients', 'patient', 'Patient'] @entity25 :: ('MESH:D012893', 'Disease') :: ['sleep disturbances'] @entity2182 :: ('MESH:D053201', 'Disease') :: ['overactive bladder']
@entity2182 :: (MESH:D053201,Disease) :: ['overactive bladder']
